Caribou Biosciences Announces Board and Executive Changes
Ticker: CRBU · Form: 8-K · Filed: Sep 3, 2024 · CIK: 1619856
| Field | Detail |
|---|---|
| Company | Caribou Biosciences, INC. (CRBU) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-composition, executive-compensation
Related Tickers: CRBU
TL;DR
Caribou Biosciences shakes up board and exec comp. New faces, new pay plans.
AI Summary
Caribou Biosciences, Inc. announced on September 1, 2024, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: medium — Board and executive changes can indicate internal shifts or strategic realignments that may carry inherent risks.
Key Players & Entities
- Caribou Biosciences, Inc. (company) — Registrant
- September 1, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Berkeley, California (location) — Principal Executive Offices
FAQ
What specific roles have seen departures or appointments?
The filing indicates the departure of certain officers and directors, and the election of new directors, along with updates to compensatory arrangements for certain officers, though specific names and roles beyond general categories are not detailed in this excerpt.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on September 1, 2024.
What is Caribou Biosciences, Inc.'s state of incorporation?
Caribou Biosciences, Inc. is incorporated in Delaware.
Where are Caribou Biosciences, Inc.'s principal executive offices located?
Caribou Biosciences, Inc.'s principal executive offices are located at 2929 7th Street, Suite 105, Berkeley, California 94710.
What is the filing's primary purpose?
The filing is a Current Report on Form 8-K, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Filing Stats: 759 words · 3 min read · ~3 pages · Grade level 11.5 · Accepted 2024-09-03 16:01:18
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value per share CRBU NASDAQ Global
Filing Documents
- crbu-20240901.htm (8-K) — 27KB
- 0001619856-24-000071.txt ( ) — 155KB
- crbu-20240901.xsd (EX-101.SCH) — 2KB
- crbu-20240901_lab.xml (EX-101.LAB) — 23KB
- crbu-20240901_pre.xml (EX-101.PRE) — 13KB
- crbu-20240901_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Caribou Biosciences, Inc. Date: September 3, 2024 By: /s/ Rachel E. Haurwitz Rachel E. Haurwitz President and Chief Executive Officer